Company

Inceptor Bio

Biotechnology Research 2405 Perimeter Park Dr 22 employees

Employees: 22
Contacts: 4
Emails: 4
Phones: 3

www.inceptor.bio LinkedIn Crunchbase

Inceptor Bio Overview

Headquarters: 2405 Perimeter Park Dr
Website: www.inceptor.bio
Industry: Biotechnology Research
Employees: 22
Founded: 2020
Funding: 21.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

CAR-T cell therapy oncology cancer therapies chimeric antigen receptors T-cell

About Inceptor Bio

Inceptor Bio is a clinical-stage biotech company pioneering next-generation cell therapies to cure cancer. Our proprietary OUTLAST™ platform reprograms T cells into persistent, stem-like cells capable of thriving in the hostile tumor microenvironment. Our thesis: Like elite athletes training at high elevation, T cells conditioned in challenging environments develop the attributes needed to thrive in the hostile tumor setting, outperforming cells grown in conventional, idealized conditions Our lead program, IB-T101, is an autologous CD70 CAR-T therapy targeting clear cell Renal Cell Carcinoma (ccRCC). Join us on our journey to redefine the future of cancer treatment.

Inceptor Bio Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 3; 75.0% coverage

Inceptor Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Christopher Heery	Chief Medical Officer at Arcellx, Inc.	Durham, North Carolina, United States	Email Phone
Shailesh Maingi	Advancing Cell and Gene Therapies	Raleigh-durham-chapel Hill Area, United States	Email Phone
Mike Nicholson, Phd	Biotechnology Enthusiast and Educator	Cary, North Carolina, United States	Email Phone
Frank Lis	General Partner	Raleigh, North Carolina, United States	Email